The Giants of Cancer Care® program, presented by OncLive®, recognizes and celebrates the individuals who have achieved landmark successes within the global field of oncology. Giants of Cancer Care® is the premier oncology awards program honoring leaders, selected by their peers, for their remarkable achievements in oncology research and clinical practice.

  • Nominations are open through April 16, 2021.
  • The Giants of Cancer Care® Steering Committee will vet all nominations to determine finalists in each category.
  • A Selection Committee of more than 120 oncologists will vote to determine the 2021 inductees.
  • The 2021 Giants of Cancer Care® class will be announced in mid-September of 2021.
  • Nominees must hold an MD, DO, or PhD.
  • Domestic and international nominations will be accepted.
  • Nominees may only be submitted by other HCPs: MDs, DOs, PhDs, RNs, RSNs, NPs, etc.
  • Posthumous nominees will not be considered.
  • Nominations will not be accepted from industry (including pharma).

This includes one round trip airfare* and a one night stay at a hotel of OncLive’s choosing. Individuals may nominate as many times as they wish, but may not nominate the same physician more than once in a single category. Each nomination for a different oncology specialist will count as a new entry into the raffle. Giants of Cancer Care® Steering Committee members, Selection Committee members, or employees of MJH Life Sciences may not enter the raffle.

*Airfare ticket will be purchased in coach class only. Certain restrictions may apply to both airfare and hotel reservations, and will be provided to the raffle winner upon notification.
**Please note that a nomination in a particular category does not ensure a winner for that category.
***If the ceremony becomes a fully virtual event, the raffle winner chosen in 2021 will be provided a trip to the next ceremony held as a live or hybrid event.

Please complete the nomination form below.

  1.  Breast Cancer
  2. Cancer Diagnostics
  3. CNS Malignancies
  4. Community Outreach / Education / Cancer Policy
  5.  Gastrointestinal Cancer
  6.  Genitourinary Cancer
  7.  Gynecologic Malignancies
  8.  Head and Neck Cancer
  9.  Hematologic Malignancies
  10.  Leukemia
  11.  Lung Cancer
  12.  Lymphoma
  13.  Melanoma & Other Skin Cancers
  14.  Myeloma
  15.  Pediatric Oncology
  16.  Prevention/Genetics
  17.  Radiation Oncology
  18.  Supportive / Palliative / Geriatric Care
  19.  Surgical Oncology
  20.  Therapeutic Development (formerly Drug Development)
  21.  Translational Science (formerly Immuno-oncology & Scientific Advances)
*To see previous inductees in each category, please click the corresponding arrow.
*First Name
*Last Name
*Key achievement
*Tumor Type and/or Specialty Category
Other, please specify:
Community Outreach, Education, and/or Cancer Policy category

The nominees for the Community Outreach/Education category educate professionals about evolving aspects of treatment and ongoing clinical trials. The nominees in this category are dedicated to furthering the field by promoting the most current research findings to their oncology colleagues.
The nominees for the Cancer Policy category maintain a sustained discussion and collaboration among national and health experts about issues relevant to preventing and treating cancer through lobbying and legislative efforts. The nominees have identified high priority policy issues in science, clinical medicine, and public health and have exhibited leadership through convening activities that promote discussion about potential opportunities for action.
Supportive/Palliative/Geriatric Care category

Nominees in the Supportive/Palliative Care category deliver care that provides comfort, support, and symptom management. This type of care prevents or treats, as early as possible, the symptoms and side effects of cancer and its treatments, and addresses the related psychological, social, and spiritual problems that can potentially accompany the diagnosis.
Nominees in the Geriatric Care category are experts in the care of older patients with cancer, who often have special needs and considerations, including increased risk of drug reactions. Nominees are integral team members who often consult with oncologists to help them determine how well a patient may tolerate a specific cancer therapy, and what precautions may need to be taken during treatment because of the patient's advanced age. They are strong advocates for the aged.
*Your Name
*Email Address
Phone Number
*Required for verification purposes only. We will not distribute your information.

Program Information:
Previous Inductees:
2013 | 2014
2015 | 2016
2017 | 2018
2019 | 2020